- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04018911
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2019_20
Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stäfa, Switzerland, 8712
- Sonova AG
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy outer ear (without previous surgical procedures)
- Ability to fill in a questionnaire conscientiously
- Informed Consent as documented by signature
Exclusion Criteria:
Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Massively limited dexterity
- Known psychological problems
- Known central hearing disorders
- colour blinded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Hearing Aid standard NR_1
Hearing Aid with standard Noise Reduction (NR) serves as reference condition.
|
Hearing Aid with standard Noise Reduction (NR) Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs (ensures exact same hearing loss compensation for each intervention).
Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort.
The active comparator condition is the state of the art Noise Reduction principle.
|
|
Experimental: Hearing Aid with NR_2
NR_2: Noise Reduction principle 2
|
Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs.
Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort.
The experimental conditions (novel NR principle) vary in their parametrization to result in different degrees of noise suppression and good speech quality.
|
|
Experimental: Hearing Aid with NR_3
NR_3: Noise Reduction principle 3
|
Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs.
Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort.
The experimental conditions (novel NR principle) vary in their parametrization to result in different degrees of noise suppression and good speech quality.
|
|
Experimental: Hearing Aid with NR_4
NR_4: Noise Reduction principle 4
|
Each participant will be fitted with the 4 different Noise Reduction (Sound Changing) principles on the same hearing aid, saved to 4 manual programs.
Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort.
This experimental condition combines standard NR and novel NR principle to result in different degrees of noise suppression and good speech quality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sound quality ratings
Time Frame: 4 weeks
|
The sound quality ratings will be assessed with the aid of a Multi-Stimulus Test.
The data, serving as the primary outcome measure, are collected in the laboratory and will use a continuous rating scale.
The scale ranges from 0 "very bad" to 100 "very good" in increments of 1.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oldenburg sentence test & reaction time task
Time Frame: 3 weeks
|
A dual task paradigm will be used in which the Oldenburg Sentence test in noise will be administered as a primary task, and the subject will press a button as fast as possible when a light appears on a screen as a secondary task.
The aim is to recall as many words from the presented sentence at a predefined SNR and press the button as fast as possible at the same time.
The data derived, serving as secondary outcome measure are he Signal to noise ratio (SNR) in decibel (dB) where a 50% speech reception threshold is reached and the reaction time (RT) in seconds and the number of missed stimuli.
and number of false alarms missed data rate.
|
3 weeks
|
|
Oldenburg Sentence test (Olsa)
Time Frame: 4 weeks
|
Oldenburg Sentence test in noise will be administered as single task.
The aim is to recall as many words from the presented sentence at different signal to noise ratios until the 50% threshold is reached.
The data derived, serving as secondary outcome measure are the Signal to noise ratio (SNR) in decibel (dB) where a 50% speech reception threshold is reached.
|
4 weeks
|
|
Adaptive Categorial Listening Effort Scaling (ACALES)
Time Frame: 3 weeks
|
The ACALES procedure determines self-reported individual listening effort on a scale from "extreme effort" to "no effort" within a signal-to-noise ratio range that corresponds to individual subject perceptions. The data, serving as a secondary outcome, are a set of points on a categorial scale (subjectively perceived listening effort) as a function of different SNRs. |
3 weeks
|
|
qualitative interview form
Time Frame: 3 weeks
|
A qualitative questionnaire with predefined questions and comment sections to gather information on individual perceptions regarding the 3 experimental conditions to the active comparator ( see study arms/ interventions for detailed descriptions) during different laboratory-based complex acoustic scenes.
The data collected from this questionnaire are scores on a continuous rating scale ranging from "0" (worst) to "10"( best).
|
3 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-verbal Trail Making Test A & B
Time Frame: 1 week
|
The Trail Making Test is a neuropsychological test of visual attention and task switching.
It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy.
The data, serving as an outcome measure, are time-to-complete the set in seconds.
|
1 week
|
|
color-word-interference test by J.R.Stroop
Time Frame: 1 week
|
The color-word- interference test ("Farb-Wort-Interferenztest nach J.R.Stroop" (version: "Günther Bäumler")) is a neuropsychological test of visual attention and interferer suppression and will be carried out in the laboratory.
In the first trial, the subject has to read the names of colours written on a card as fast and accurately as possible.
In the second trial, the subject has to name the colour ink of filled boxes on a card as quickly and accurately as possible.
In the third trial, the names of colours are written on a card in a dissimilarly coloured ink.
The participant must read aloud the written words, whilst ignoring the colour of the ink.
The data, serving as an outcome measure, are time-to-complete the sets in seconds.
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Juliane Raether, Sonova AG
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sonova2019_20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Wonju Severance Christian HospitalRecruitingHearing Loss, Sudden | Sudden Hearing Loss | Hearing Loss, Idiopathic Sudden Sensorineural | SSNHL(Sudden Sensory Neural Hearing Loss)Korea, Republic of
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Hearing Aid with standard Noise Reduction (NR_1)
-
Sebastian GriepentrogNot yet recruiting
-
Sonova AGCompleted
-
Purdue UniversityOticonRecruitingHearing Loss, CochlearUnited States
-
Sonova AGToronto Metropolitan UniversityCompleted
-
Sonova AGCompleted
-
Sonova AGWestern UniversityRecruiting
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Sonova AGCompletedHearing Loss | Normal HearingSwitzerland
-
Sonova AGCompleted